2-((4-(pyridin-2-yldiazenyl)phenyl)ethynyl)pyridine

ID: ALA4101860

PubChem CID: 137661714

Max Phase: Preclinical

Molecular Formula: C18H12N4

Molecular Weight: 284.32

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C(#Cc1ccccn1)c1ccc(/N=N\c2ccccn2)cc1

Standard InChI:  InChI=1S/C18H12N4/c1-3-13-19-16(5-1)10-7-15-8-11-17(12-9-15)21-22-18-6-2-4-14-20-18/h1-6,8-9,11-14H/b22-21-

Standard InChI Key:  CWAVNLYIGIXETP-DQRAZIAOSA-N

Molfile:  

     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   29.2302   -0.9760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.9374   -1.3855    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.9363   -2.2027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2271   -2.6056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2256   -3.4220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9333   -3.8324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6439   -3.4203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6419   -2.6053    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.1103   -1.3908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1092   -2.2104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8172   -2.6193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5269   -2.2099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5241   -1.3872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8155   -0.9820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4012   -2.6184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6879   -3.0211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9763   -3.4229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2754   -3.0033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.5643   -3.4043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5560   -4.2224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2647   -4.6376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9730   -4.2342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 10 15  1  0
 15 16  3  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 13  1  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4101860

    ---

Associated Targets(non-human)

Grm5 Metabotropic glutamate receptor 5 (4372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 284.32Molecular Weight (Monoisotopic): 284.1062AlogP: 4.29#Rotatable Bonds: 2
Polar Surface Area: 50.50Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.03CX LogP: 5.05CX LogD: 5.05
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.52Np Likeness Score: -1.10

References

1. Gómez-Santacana X, Dalton JAR, Rovira X, Pin JP, Goudet C, Gorostiza P, Giraldo J, Llebaria A..  (2017)  Positional isomers of bispyridine benzene derivatives induce efficacy changes on mGlu5 negative allosteric modulation.,  127  [PMID:28109949] [10.1016/j.ejmech.2017.01.013]

Source